暴发性心肌炎:国际队列研究中的结局预测因素
院内死亡率和1年死亡率分别为31%和34%,巨细胞性心肌炎1年死亡率最高(54%)。年龄较大、较低pH值和巨细胞性心肌炎诊断与院内及1年死亡率独立相关。
要点
- 暴发性心肌炎院内死亡率高(31%),巨细胞性心肌炎1年死亡率达54%。
- 年龄较大、较低pH值及巨细胞性心肌炎是死亡的独立预测因素。
- 存活出院者长期功能结局和心室功能恢复良好。
核心结论
- 暴发性心肌炎患者院内死亡率仍较高,年龄、pH值和组织病理学发现可作为预后标志物识别高危患者并指导治疗策略。
- 存活出院患者长期结局优秀。
研究设计与样本
- 根据心内膜心肌活检(EMB)结果将患者分为淋巴细胞性心肌炎(LM,n=99)、嗜酸性心肌炎(EM,n=18)、坏死性嗜酸性心肌炎(NEM,n=3)和巨细胞性心肌炎(GCM,n=26);组织病理学不确定(n=48)或未行EMB(n=77)者单独分析。
- 主要结局为院内死亡率和1年死亡率,采用多变量逻辑回归模型分析预设风险因素与死亡率的关联。
主要发现
- 总体人群院内死亡率为31%,1年死亡率为34%。
- 随访期间17例患者(6%)接受了心脏移植。
- 存活出院患者功能结局优秀且心室功能长期恢复。
- 年龄较大、较低pH值和巨细胞性心肌炎诊断与院内及1年死亡率独立相关。
关键数值与推荐
- 组织病理学亚组间心脏骤停率、入院简化急性生理评分(SAPS)II、心室功能、初始pH值及肝肾功能参数无显著差异。
- 免疫抑制药物使用和器官替代需求在组织病理学亚组间存在差异。
临床怎么用
- 年龄较大、较低pH值和巨细胞性心肌炎诊断可用于识别暴发性心肌炎高危患者并指导治疗策略。
- 存活出院患者长期预后良好,应注重出院后长期管理。
局限性
- 回顾性研究设计。
- 部分患者未行EMB或组织病理学结果不确定,影响组织病理学亚组分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Fulminant myocarditis (FM) is a complex clinical syndrome characterized by acute myocardial inflammation and cardiogenic shock. Evidence on long-term outcomes, mortality risk factors, and targeted treatment options remains limited. METHODS: This retrospective analysis included consecutive adult patients admitted for FM between January 2012 and November 2022 at 26 European tertiary centres. According to endomyocardial biopsy (EMB) findings, patients were categorized as lymphocytic (LM), eosinophilic (EM), necrotizing eosinophilic (NEM), and giant-cell myocarditis (GCM) for the main analyses. Patients with inconclusive histopathology and those who did not undergo EMB were analysed separately. Primary outcomes were in-hospital and 1-year mortality. Multivariable logistic regression models were employed as generalized linear models to analyse the association of prespecified risk factors with mortality. Estimated associations are reported as odds ratios, generalized marginal effects, and adjusted prediction plots. RESULTS: A total of 271 patients [median age 43 years (interquartile range: 33-55 years), 58% male] were included in the analysis, of whom 146 fulfilled histopathologic criteria of LM (n = 99), EM (n = 18), NEM (n = 3), or GCM (n = 26). In the remaining 125 cases, EMB was inconclusive (n = 48) or not performed (n = 77). While there were no significant differences in cardiac arrest rate, admission Simplified Acute Physiology Score (SAPS) II, ventricular function, initial pH, and liver and kidney function parameters between histopathologic subgroups, the use of immunosuppressive medications and need for organ replacement varied. In the overall population, in-hospital and 1-year mortality were 31% and 34%, respectively. The highest 1-year mortality rate was observed among patients with GCM (LM: 25%, EM: 28%, NEM: 33%, GCM: 54%, P = .04). Patients who survived to discharge had an excellent functional outcome and long-term recovery of ventricular function. In total, 17 patients (6%) received a heart transplant during follow-up. Older age, lower pH, and histopathologic diagnosis of GCM were independently associated with in-hospital and 1-year mortality. CONCLUSIONS: In-hospital mortality among patients with FM remains high. Age, pH, and histopathological findings may serve as prognostic markers to identify high-risk patients and to guide treatment strategies. Long-term outcomes are excellent among those who survive to discharge.
引用
- Majunke, Haertel, Binzenhöfer, et al. Fulminant myocarditis: outcome predictors in an international cohort study. Eur Heart J. 2025. PMID: 40928499. doi:10.1093/eurheartj/ehaf671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。